Nonclinical Carcinogenicity Studies: Fundamentals, Case Studies and Regulatory Trends

Dr. Susanne Stalford, Lhasa Principal Scientist, presented within a Pharmaceutical & BioScience Society workshop, on the topic of Nonclinical Carcinogenicity Studies. The workshop included presentations from regulatory and industry perspectives, on topics relating to carcinogenicity assessment of pharmaceuticals, including: The challenges faced with carcinogenicity assessments, in the development of pharmaceuticals Regulatory and industry perspectives on […]

Nonclinical Carcinogenicity Studies: Fundamentals, Case Studies and Regulatory Trends Read More »

Supporting mutagenic impurity and degradant risk assessment using an in silico approach

catherine.trio

We recently held our first webinar of 2023, ‘Supporting mutagenic impurity and degradant risk assessment using an in silico approach’. This free-to-attend webinar featured talks from Dr. Andreas Broehl, Laboratory Head at Bayer Pharmaceuticals, and Lhasa Limited Senior Scientist, Dr. Ash Ali. In this exciting virtual event, we explored how our in silico software solution Zeneth, can

Supporting mutagenic impurity and degradant risk assessment using an in silico approach Read More »

United States Pharmacopeia (USP) Workshop on Nitrosamine Impurities

catherine.trio

We were excited to attend USP’s Workshop on Nitrosamine Impurities, organised by United States Pharmacopeia (USP) in collaboration with Indian Pharmaceutical Alliance (IPA). Lhasa Principal Scientist, David Ponting presented within the Toxicity Assessment session, his presentation was titled ‘Application of in silico tools (QSAR) to predict toxicity’.

United States Pharmacopeia (USP) Workshop on Nitrosamine Impurities Read More »

Supporting skin sensitisation risk assessment using in silico tools

triomedia

Dr. Anne Marie Api is Vice President at the Research Institute for Fragrance Materials (RIFM), directing RIFM’s extensive research programs and is co-author of the Quantitative Risk Assessment (QRA) for dermal sensitization. We were delighted to have Anne Marie present within our webinar, ‘Supporting skin sensitisation risk assessment using in silico tools‘. In addition, Dr. Martyn Chilton, Principal Scientist at Lhasa Limited discussed our

Supporting skin sensitisation risk assessment using in silico tools Read More »

ELSIE Webinar: Framework for Sensitization Assessment of E&Ls and Practical Application

triomedia

We were thrilled to participate in the Extractables and Leachables Safety Information Exchange (ELSIE) Consortium webinar, titled ‘Framework for Sensitization Assessment of E&Ls and Practical Application’. Lhasa Principal Scientist, Martyn Chilton was a presenter and panellist at this event. Martyn’s talk detailed his work analysing the sensitisation potency of extractables and leachables in collaboration with

ELSIE Webinar: Framework for Sensitization Assessment of E&Ls and Practical Application Read More »

Zeneth Webinar Series – Zeneth, the trusted predictive degradation expert: Industry use cases and new science

triomedia

We were delighted to bring you a 2022 Global Zeneth Webinar series. Our Zeneth webinar series ran throughout June 2022 and consisted of a total of 7 Zeneth focused webinars held at different time, and in some cases, different languages, to accommodate different audiences around the world. The main topics discussed in this webinar were: – How Zeneth works, and how Zeneth is aligned with regulatory guidelines – Mechanistic understanding of degradation pathways – Use

Zeneth Webinar Series – Zeneth, the trusted predictive degradation expert: Industry use cases and new science Read More »

An Introduction to Nitrite in Excipient Testing to Accelerate Route Cause Investigation of Nitrosamines

triomedia

We were delighted to bring you the webinar: An Introduction to Nitrite in Excipient Testing to Accelerate Route Cause Investigation of Nitrosamines. This exciting event included presentations from: Name:Dr. Joerg Schlingemann Title/Organisation:Merck Bio: Joerg Schlingemann is a Director and Principal Expert for Quality Control Systems within Merck KGaA’s / EMD Serono’s Healthcare Quality Unit. Joerg studied Molecular Biology in Uppsala and Heidelberg, where he completed a Doctorate degree

An Introduction to Nitrite in Excipient Testing to Accelerate Route Cause Investigation of Nitrosamines Read More »

Webinar | Controlling potentially mutagenic impurities – hear from industry experts!

triomedia

We were delighted to welcome Andrew Teasdale PhD and Muzaffar Khan PhD to present within our webinar; Controlling potentially mutagenic impurities – hear from industry experts! Andrew is currently the chair of AstraZeneca’s Impurity Advisory Board and has a wealth of knowledge developed over the last 20 years of working within the pharmaceutical industry. He is a leading AZ expert for a number of key impurity

Webinar | Controlling potentially mutagenic impurities – hear from industry experts! Read More »

Online

Nonclinical Carcinogenicity Studies: Fundamentals, Case Studies and Regulatory Trends

Supporting mutagenic impurity and degradant risk assessment using an in silico approach

United States Pharmacopeia (USP) Workshop on Nitrosamine Impurities

Supporting skin sensitisation risk assessment using in silico tools

ELSIE Webinar: Framework for Sensitization Assessment of E&Ls and Practical Application

Zeneth Webinar Series – Zeneth, the trusted predictive degradation expert: Industry use cases and new science

An Introduction to Nitrite in Excipient Testing to Accelerate Route Cause Investigation of Nitrosamines

Webinar | Controlling potentially mutagenic impurities – hear from industry experts!

Sign up to our newsletter

Connect with us